Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.68−0.07 (-8.81%)
Close on Nov 12, 2026Market cap $22.22MP/E –Yield –
Celularity total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Celularity's total debt was $33.81M at Dec 31, 2025. For fiscal 2025 it was $33.81M, down 13.8% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.81M | -13.8% |
| FY2023 | Dec 31, 2023 | $39.24M | +4.4% |
| FY2022 | Dec 31, 2022 | $37.60M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $33.81M | -20.6% |
| Q3 FY2025 | Sep 30, 2025 | $35.67M | -13.0% |
| Q2 FY2025 | Jun 30, 2025 | $6.30M | -84.2% |
| Q1 FY2025 | Mar 31, 2025 | $6.30M | -83.9% |
| Q3 FY2024 | Sep 30, 2024 | $42.61M | +204.2% |
| Q2 FY2024 | Jun 30, 2024 | $41.00M | +143.8% |
| Q1 FY2024 | Mar 31, 2024 | $39.80M | +28.6% |
| Q4 FY2023 | Dec 31, 2023 | $39.24M | +4.4% |
| Q3 FY2023 | Sep 30, 2023 | $14.01M | -64.3% |
| Q2 FY2023 | Jun 30, 2023 | $16.82M | – |
| Q1 FY2023 | Mar 31, 2023 | $30.95M | – |
| Q4 FY2022 | Dec 31, 2022 | $37.60M | – |
| Q3 FY2022 | Sep 30, 2022 | $39.26M | – |
See a number that looks wrong?